Type VI Protein Secretion in an Emerging Multidrug-Resistant Pathogen

新兴多重耐药病原体中的 VI 型蛋白分泌

• 批准号: 8254576
• 负责人: Edward Geisinger
• 金额: $ 5.39万
• 依托单位: TUFTS UNIVERSITY BOSTON
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-07-03 至 2015-07-02
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8254576
• 关键词: Acinetobacter; Acinetobacter baumannii; Address; Adherence; Adhesions; Animal Model; Anti-Infective Agents; Antibiotic Resistance; Bacteria; Cell Culture Techniques; Cell physiology; Cells; Clinical; Communicable Diseases; Disease; Drug resistance; Educational process of instructing; Environment; Epidemic; Epithelial; Epithelial Cells; Goals; Growth; Human; Immune; Immune response; Immunity; In Vitro; Infection; Inflammation; Knowledge; Legionella pneumophila; Lesion; Mammalian Cell; Measures; Microbe; Modeling; Molecular Biology; Morbidity - disease rate; Multi-Drug Resistance; Mus; Nosocomial Infections; Pasteurella pseudotuberculosis; Pathogenesis; Pathogenicity; Pathology; Patients; Play; Pneumonia; Protein Secretion; Protein translocation; Proteins; Reporter; Research; Resistance; Role; Sepsis; Specificity; System; Techniques; Testing; Therapeutic; Tissues; Toxic effect; Training; Vaccines; Virulence; Work; clinical phenotype; cytotoxicity; drug resistant bacteria; experience; genome wide association study; immunoregulation; mortality; mouse model; mutant; new therapeutic target; novel; pathogen; prevent; research study

DESCRIPTION (provided by applicant): Hospital-acquired infections due to multidrug-resistant bacteria are a major cause of increased morbidity and mortality in patients with weakened immunity. A leading agent of such infections is the bacterium Acinetobacter baumannii. This microbe causes invasive infections, including pneumonia and sepsis, that in recent years have become increasingly severe and antibiotic-resistant, raising the specter that they may one day be untreatable. New ways to prevent and treat infections with A. baumannii are urgently needed, but alarmingly little is known about how these bacteria cause disease. Recent evidence indicates that these bacteria induce adherence-dependent cytotoxicity toward cultured epithelial cells; however, the mechanisms used by A. baumannii to intoxicate cells upon adhesion are unclear. The goal of the proposed studies is to understand how these microbes interact with human cells and how such interactions undermine normal cellular processes, promoting infection. Towards this goal, this proposal aims to characterize in detail a contact-dependent protein delivery system, known as a Type VI Secretion System (T6SS) that is present in clinical strains of A. baumannii responsible for recent epidemics. These systems play a role in host infections by a range of microbes, but the system is undefined in A. baumannii. The proposed work will determine which cells are targeted by the A. baumannii T6SS, identify the effector proteins it sends into these cells, and examine the functional roles of the system and its effectors in host interactions and pathogenesis. These aims will be accomplished by analyzing the transfer of reporter fusions into target cells, conducting directed genome-wide screens for effectors, and examining the effects of T6SS- and effector-null mutants on bacterial toxicity and the host innate immune response during interactions with host cells in culture and in a murine model of pneumonia. These studies will break new ground on the mechanisms used by A. baumannii to promote infection and will address key gaps in our understanding of T6SS pathobiology. Ultimately, this information will uncover targets for novel anti-infective treatments and vaccines against highly drug- resistant bacteria. The training experience will broaden my expertise in molecular biology, teach me new techniques in mammalian cell culture and animal models, and advance my understanding of the pathogenesis of infectious diseases. PUBLIC HEALTH RELEVANCE: Acinetobacter baumannii, a frequent cause of invasive, hospital-acquired infections, has become more drug resistant and aggressive in recent years. The proposed research is aimed at understanding how the bacterium interacts with cells within the infected host in a way that promotes bacterial growth and misregulation of host cells. This knowledge will expose potential targets for novel anti-infective therapeutics against these highly resistant microbes.!

描述（由申请人提供）：由耐多药细菌引起的医院获得性感染是免疫力低下患者发病率和死亡率增加的主要原因。这种感染的主要病原体是鲍曼不动杆菌。这种微生物会引起侵袭性感染，包括肺炎和败血症，近年来，这种感染变得越来越严重，对抗生素也越来越耐药，这让人担心，有一天这些感染可能无法治愈。目前迫切需要预防和治疗鲍曼不动杆菌感染的新方法，但令人震惊的是，人们对这些细菌是如何致病的知之甚少。最近的证据表明，这些细菌对培养的上皮细胞诱导粘附依赖性细胞毒性；然而，鲍曼不动杆菌在细胞粘附时中毒的机制尚不清楚。拟议研究的目标是了解这些微生物如何与人类细胞相互作用，以及这种相互作用如何破坏正常的细胞过程，促进感染。为了实现这一目标，本提案旨在详细描述一种依赖于接触的蛋白质递送系统，称为VI型分泌系统（T6SS），该系统存在于导致最近流行病的鲍曼不动杆菌临床菌株中。这些系统在一系列微生物的宿主感染中发挥作用，但该系统在鲍曼不动杆菌中不明确。这项工作将确定鲍曼不动杆菌T6SS靶向哪些细胞，鉴定其发送到这些细胞中的效应蛋白，并研究该系统及其效应蛋白在宿主相互作用和发病机制中的功能作用。这些目标将通过分析报告融合物向靶细胞的转移，对效应物进行定向全基因组筛选，并在培养和小鼠肺炎模型中检查T6SS和效应物无效突变体对细菌毒性和宿主先天免疫反应的影响。这些研究将为鲍曼不动杆菌促进感染的机制开辟新的领域，并将解决我们对T6SS病理生物学理解的关键空白。最终，这些信息将揭示新的抗感染治疗的靶点